Virtual reality-based meditation for enhancement of wellbeing, quality of life and patient satisfaction for in-patients undergoing chemotherapy

Not Applicable

Recruiting

• Conditions: C34; C92.0; C91.0; Malignant neoplasm of bronchus and lung; Acute myeloblastic leukaemia [AML]; Acute lymphoblastic leukaemia [ALL]

• Registration Number: DRKS00024663
• Lead Sponsor: niversitätsklinikum Augsburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Adult patients capable of consent who are receiving inpatient chemotherapy for lung cancer or acute myeloid or acute lymphatic leukemia.

Exclusion Criteria

Non-consenting patients; minor patients; pregnant patients; patients admitted as emergencies; patients participating in another intervention study that may have a potential impact on the endpoints of this study; Patients with infectious disease and need for isolation, pre-existing dementia, schizophrenia, hallucinations, panic attacks, or epileptic seizures; pacemaker or defibrillator wearers; patients taking neuroleptics or antiepileptic drugs; patients with active alcohol and/or drug abuse; lack of proficiency in German or English.

Study & Design

• Study Type: interventional
• Study Design: Not specified